T1	Participants 87 134	Mexican patients with type 2 diabetes mellitus:
T2	Participants 573 662	Mexican patients with type 2 diabetes who received pioglitazone or glimepiride for 1 year
T3	Participants 1551 1623	Two hundred forty-four patients (125 women, 119 men; all but 1 Hispanic)